The controversial role of Sirtuins in tumorigenesis-SIRT7 joins the debate

Cell Research

Volumn 23, Issue 1, 2013, Pages 10-12

  Li, Ling ^a   Bhatia, Ravi ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELK4 PROTEIN, HUMAN; HISTONE; RIBOSOME PROTEIN; SIRT7 PROTEIN, HUMAN; SIRTUIN; TRANSCRIPTION FACTOR ELK 4;

ACETYLATION; ANIMAL; CELL TRANSFORMATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PROMOTER REGION; REVIEW;

ACETYLATION; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; ETS-DOMAIN PROTEIN ELK-4; HISTONES; HUMANS; PROMOTER REGIONS, GENETIC; RIBOSOMAL PROTEINS; SIRTUINS;

MAMMALIA;

EID: 84872012326     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2012.112     Document Type: Review

References (12)

1. Liu T, Liu PY, Marshall GM. The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res 2009; 69: 1702-1705.
2. Deng CX. SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 2009; 5: 147-52.
3. Vakhrusheva O, Smolka C, Gajawada P, et al. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res 2008; 102: 703-710. (Pubitemid 351457857)
4. Voelter-Mahlknecht S, Letzel S, Mahlknecht U. Fluorescence in situ hybridization and chromosomal organization of the human Sirtuin 7 gene. Int J Oncol 2006; 28: 899-908.
5. Du J, Zhou Y, Su X, et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011; 334: 806-809.
6. Tsai YC, Greco TM, Boonmee A, et al. Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription. Mol Cell Proteomics 2012; 11: 60-76.
7. Barber M, Michishita-Kioi E, Xi Y, et al. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 2012; 487: 114-118.
8. Manuyakorn A, Paulus R, Farrell J, et al. Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J Clin Oncol 2010; 28: 1358-1365.
9. Makkonen H, Jääskeläinen T, Pitkänen-Arsiola T, et al. Identification of ETSlike transcription factor 4 as a novel androgen receptor target in prostate cancer cells. Oncogene 2008; 27: 4865-4876.
10. Kurdistani SK, Tavazoie S, Grunstein M. Mapping global histone acetylation patterns to gene expression. Cell 2004; 117: 721-733. (Pubitemid 38748889)
11. Ebert BL, Pretz J, Bosco J, et al. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature 2008; 451: 335-339.
12. Li L, Wang L, Li L, et al. Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell 2012; 21: 266-281.